Overview
Mermaid diagram (expand to render)
OpenBCI is an open-source [brain](/brain-regions/overview)-computer interface](/brain-regions/overview)-computer-interface) ([BCI](/brain-regions/overview)-computer-interface)) platform that provides affordable, accessible [EEG](/technologies/eeg)) ([electroencephalography](/technologies/eeg)) hardware and software for research, education, and healthcare applications. Founded in 2013, OpenBCI has democratized neurotechnology by offering low-cost, open-source alternatives to commercial [EEG](/technologies/eeg)) systems, enabling researchers and developers to conduct neuroscience research and develop [BCI](/brain-regions/overview)-computer-interface) applications without prohibitive expenses["@openbci2024"].
Hardware Ecosystems
OpenBCI provides a comprehensive range of [EEG](/technologies/eeg)) hardware platforms designed for different use cases:
Cyton Board
The Cyton is an 8-channel biosensing board designed for research applications. It features:
- 8 differential [EEG](/technologies/eeg)) channels with 24-bit ADC resolution
- Sampling rate up to 500 Hz (or 250 Hz with daisy module)
- Integrated accelerometer for motion tracking
- Bluetooth Classic wireless connectivity
- Compatible with dry electrodes or wet [EEG](/technologies/eeg)) caps
The Cyton serves as the flagship research platform, offering a balance of channel count, signal quality, and accessibility[@openbci2024].
Ganglion Board
The Ganglion is a compact, portable 4-channel system optimized for:
- Mobile and wearable applications
- Real-world [EEG](/technologies/eeg)) monitoring
- Rapid prototyping and education
- Consumer neurotechnology development
Despite reduced channel count, the Ganglion maintains 14-bit resolution and offers superior portability for applications requiring movement and field research[@openbci2024].
Ultracortex Headset
The Ultracortex is an open-source wearable [EEG](/technologies/eeg)) headset available in two versions:
- Mark IV: 8-channel configuration with dry-contact electrodes
- Supernova: 32-channel high-density array
The Ultracortex uses spring-loaded dry electrodes that eliminate the need for conductive gel, significantly reducing setup time and enabling rapid data collection[@mccrimmon2017].
Cyton+Daisy Configuration
Combining the Cyton with the Daisy module enables 16-channel high-density recording, suitable for:
- High-resolution source localization
- Advanced signal processing research
- [brain](/brain-regions/overview)-computer interface](/brain-regions/overview)-computer-interface) development requiring greater spatial resolution
Software Ecosystem
OpenBCI's software stack provides end-to-end functionality:
OpenBCI GUI
The graphical user interface enables:
- Real-time signal visualization
- Data recording to multiple formats (CSV, BDF, FIF)
- Built-in filters and preprocessing
- Hardware configuration and calibration
BrainFlow
BrainFlow is a unified library that provides:
- Cross-platform data acquisition API
- Support for 20+ [EEG](/technologies/eeg)) devices beyond OpenBCI
- Python, C++, Java, and Rust bindings
- Real-time signal processing pipelines[@brainflow2024]
Lab Streaming Layer (LSL)
LSL enables:
- Real-time data streaming to analysis software
- Synchronization with physiological and environmental sensors
- Integration with psychophysics and stimulus presentation tools
PyOpenBCI
The Python API enables:
- Custom signal processing pipelines
- Machine learning integration for [BCI](/brain-regions/overview)-computer-interface) classification
- Real-time feedback and neurofeedback applications
Research Applications in [neurodegeneration](/diseases/neurodegeneration)
[Alzheimer's](/diseases/alzheimers-disease) disease](/diseases/alzheimers-disease) and [mild cognitive impairment](/diseases/mild-cognitive-impairment)
[EEG](/technologies/eeg))-based have emerged as promising tools for early detection and monitoring of [Alzheimer's](/diseases/alzheimers-disease) disease](/diseases/alzheimers-disease) (AD) and [mild cognitive impairment](/diseases/mild-cognitive-impairment) ([MCI](/diseases/mild-cognitive-impairment))[@dauwan2021][@cassani2023]. OpenBCI platforms facilitate research in:
Quantitative [EEG](/technologies/eeg)) (qEEG) Biomarkers
- Reduced alpha power and increased delta/theta power correlate with [cognitive decline](/mechanisms/cognitive-decline)
- Decreased alpha/theta ratio predicts progression from [MCI](/diseases/mild-cognitive-impairment) to AD
- Coherence abnormalities in temporal-parietal regions distinguish AD from healthy aging
Event-Related Potentials (ERPs)
- Reduced [P300](/mechanisms/event-related-potentials) amplitude and latency prolongation indicate cognitive processing deficits
- Mismatch negativity (MMN) abnormalities predict conversion from [MCI](/diseases/mild-cognitive-impairment) to AD
Resting-State Networks
- Disrupted [default mode network](/mechanisms/default-mode-network) ([DMN](/mechanisms/default-mode-network)) connectivity detectable with high-density [EEG](/technologies/eeg))
- Reduced alpha desynchronization during cognitive tasks
OpenBCI's affordability enables larger cohort studies and longitudinal monitoring that would be prohibitively expensive with commercial systems[@musaeus2022].
[Parkinson's](/diseases/parkinsons-disease) disease](/diseases/parkinsons-disease)
[EEG](/technologies/eeg)) research in [Parkinson's](/diseases/parkinsons-disease) disease](/diseases/parkinsons-disease) (PD) focuses on:
Motor [Cortex](/brain-regions/overview)-regions/cortex) Activity
- Elevated beta-band oscillations (13-30 Hz) correlate with bradykinesia and rigidity
- Pathological entrainment between [basal ganglia](/brain-regions/overview)-regions/basal-ganglia) and [motor cortex](/brain-regions/overview)-regions/motor-cortex)
Cognitive Impairment Detection
- Theta-band hyperconnectivity predicts PD-associated [dementia](/diseases/dementia)
- Reduced [P300](/mechanisms/event-related-potentials) amplitude correlates with executive dysfunction
[deep brain stimulation](/brain-regions/overview)-stimulation) Monitoring
- [EEG](/technologies/eeg)) can optimize stimulation parameters
- Closed-loop systems may reduce side effects
OpenBCI platforms enable development of portable monitoring systems for PD patients[@mo2023][@sharma2023].
[ALS](/diseases/amyotrophic-lateral-sclerosis)](/diseases/amyotrophic-lateral-sclerosis) ([ALS](/diseases/amyotrophic-lateral-sclerosis))
For patients with [locked-in syndrome](/diseases/locked-in-syndrome) or complete paralysis:
- [P300](/mechanisms/event-related-potentials)-based communication [BCI](/brain-regions/overview)-computer-interface) enables yes/no communication
- SSVEP systems achieve communication rates of 5-8 selections per minute
- Motor imagery [BCI](/brain-regions/overview)-computer-interface) provides alternative control channels
OpenBCI has been used to develop low-cost AAC (augmentative and alternative communication) devices for [ALS](/diseases/amyotrophic-lateral-sclerosis) patients[@wolpaw2002][@kbler2009].
Clinical Evidence for [EEG](/technologies/eeg))-Based BCIs
Diagnostic Accuracy
Multiple studies validate [EEG](/technologies/eeg)) for [neurodegeneration](/diseases/neurodegeneration):
| Condition | Sensitivity | Specificity | Key Biomarkers |
|-----------|-------------|-------------|----------------|
| AD vs. Healthy | 85-90% | 80-85% | Alpha/theta ratio, [P300](/mechanisms/event-related-potentials) latency |
| [MCI](/diseases/mild-cognitive-impairment) conversion | 75-82% | 78-83% | Resting-state connectivity |
| PD [dementia](/diseases/dementia) | 88-92% | 82-86% | Beta coherence, [P300](/mechanisms/event-related-potentials) amplitude |
Meta-analyses indicate [EEG](/technologies/eeg)) provides 80-85% accuracy for AD screening, comparable to more expensive neuroimaging[@dauwan2021][@cassani2023].
Longitudinal Monitoring
[EEG](/technologies/eeg)) offers unique advantages for disease progression tracking:
- Non-invasive, repeatable measurements
- Suitable for home monitoring with portable systems
- Cost-effective for frequent assessments
- Sensitive to treatment response
Studies demonstrate [EEG](/technologies/eeg)) changes precede clinical progression by 6-12 months, enabling predictive modeling[@musaeus2022][@babiloni2019].
Rehabilitation and Quality of Life
[BCI](/brain-regions/overview)-computer-interface)-based interventions show promise:
- Neurofeedback training improves attention and memory in [MCI](/diseases/mild-cognitive-impairment) patients
- Motor imagery [BCI](/brain-regions/overview)-computer-interface) supports stroke rehabilitation
- Communication [BCI](/brain-regions/overview)-computer-interface) enhances quality of life for locked-in patients
Randomized trials demonstrate cognitive benefits from [EEG](/technologies/eeg))-guided neurofeedback in early AD[@liew2022].
Comparison to Other Non-Invasive Approaches
[EEG](/technologies/eeg)) vs. fMRI
| Feature | [EEG](/technologies/eeg)) | fMRI |
|---------|-----|------|
| Temporal resolution | Milliseconds | Seconds |
| Spatial resolution | 2-3 cm (high-density) | 1-2 mm |
| Cost | $1,000-10,000 | $500,000-2,000,000 |
| Portability | High (portable) | Very low (fixed) |
| Invasive risk | None | None |
| Patient tolerance | High | Moderate |
[EEG](/technologies/eeg)) provides superior temporal resolution and portability; fMRI offers better spatial resolution. Combined [EEG](/technologies/eeg))-fMRI provides complementary information[@huster2012].
[EEG](/technologies/eeg)) vs. fNIRS
| Feature | [EEG](/technologies/eeg)) | fNIRS |
|---------|-----|-------|
| Signal source | Electrical (neurons) | Hemodynamic (blood flow) |
| Temporal resolution | Milliseconds | Seconds |
| Penetration depth | Whole [brain](/brain-regions/overview) | 2-3 cm (cortical) |
| Motion sensitivity | Moderate | Low |
| Cost | $1,000-10,000 | $20,000-80,000 |
fNIRS provides better spatial localization for cortical regions but limited depth. Combined [EEG](/technologies/eeg))-fNIRS systems leverage complementary signals[@chiarelli2016].
[EEG](/technologies/eeg)) vs. MEG
| Feature | [EEG](/technologies/eeg)) | MEG |
|---------|-----|-----|
| Signal source | Post-synaptic currents | Magnetic fields |
| Spatial resolution | 2-3 cm | 1-2 mm |
| Cost | $1,000-10,000 | $2,000,000-5,000,000 |
| Environmental constraints | Minimal | Shielded room required |
| Clinical availability | Wide | Limited |
MEG offers superior spatial resolution but at dramatically higher cost and with significant environmental constraints.
Future Directions
Machine Learning Integration
Advances in ML enable:
- Automated biomarker extraction and classification
- Individualized predictive models
- Real-time adaptive [BCI](/brain-regions/overview)-computer-interface) systems
- Multi-modal data fusion
Closed-Loop Systems
Emerging applications include:
- Adaptive neurofeedback for cognitive enhancement
- Responsive [neural](/cell-types/neurons) stimulation interfaces
- Predictive seizure detection
- Sleep stage monitoring and optimization
Miniaturization
Next-generation devices will enable:
- Fully dry electrode systems
- Integrated AI processing at the edge
- 24/7 wearable [brain](/brain-regions/overview) monitoring
- Consumer-grade neurotechnology
Technical Specifications Summary
| Platform | Channels | Resolution | Sampling Rate | Connectivity |
|----------|----------|-------------|---------------|--------------|
| Cyton | 8 | 24-bit | 500 Hz | Bluetooth |
| Ganglion | 4 | 14-bit | 250 Hz | Bluetooth/WiFi |
| Ultracortex Mark IV | 8 | 24-bit | 500 Hz | Bluetooth |
| Ultracortex Supernova | 32 | 24-bit | 500 Hz | Bluetooth |
| Cyton+Daisy | 16 | 24-bit | 250 Hz | Bluetooth |
Relevance to [neurodegeneration](/diseases/neurodegeneration) Research
OpenBCI enables several key research directions:
Accessible Biomarker Discovery — Low cost enables larger cohorts and longitudinal studies
Early Detection — Portable systems enable screening in community settings
Home Monitoring — Wearable devices support continuous monitoring
Intervention Development — Platform supports [BCI](/brain-regions/overview)-computer-interface)-based rehabilitation research
Patient-Centered Design — Open-source nature enables customization for specific needsRelevant Mechanisms
OpenBCI's non-invasive [EEG](/technologies/eeg)) technology interfaces with several key [neurodegenerative](/diseases/neurodegeneration) disease :
- [motor cortex](/brain-regions/overview)-regions/motor-cortex) — Primary target for movement-related [EEG](/technologies/eeg)) signal detection
- Neuroplasticity — [EEG](/technologies/eeg))-based neurofeedback can enhance cortical plasticity
- Synaptic Transmission — [neural](/cell-types/neurons) signal decoding leverages synaptic activity patterns
- Cortical Oscillations — Alpha, beta, and gamma oscillations are key signals for [BCI](/brain-regions/overview)-computer-interface) control
- BDNF Signaling — Neurotrophic factors support [neural](/cell-types/neurons) health during [BCI](/brain-regions/overview)-computer-interface) training
- [Parkinson's](/diseases/parkinsons-disease) disease](/diseases/parkinsons-disease) — Motor symptom monitoring and neurofeedback
- [Alzheimer's](/diseases/alzheimers-disease) disease](/diseases/alzheimers-disease) — Cognitive function assessment
- [ALS](/diseases/amyotrophic-lateral-sclerosis)](/diseases/amyotrophic-lateral-sclerosis) ([ALS](/diseases/amyotrophic-lateral-sclerosis)) — Communication interfaces
- Stroke — Motor rehabilitation
- [Alzheimer's](/diseases/alzheimers-disease) disease](/diseases/alzheimers-disease) — [EEG](/technologies/eeg))-based cognitive assessment and biomarker discovery
- [Parkinson's](/diseases/parkinsons-disease) disease](/diseases/parkinsons-disease) — [motor cortex](/brain-regions/overview)-regions/motor-cortex) monitoring and [deep brain stimulation](/brain-regions/overview)-stimulation) optimization
- [mild cognitive impairment](/diseases/mild-cognitive-impairment) — Early detection and progression prediction
- [ALS](/diseases/amyotrophic-lateral-sclerosis)](/diseases/amyotrophic-lateral-sclerosis) — Communication [BCI](/brain-regions/overview)-computer-interface) for locked-in patients
- Epilepsy — Seizure detection and prediction systems
- [brain](/brain-regions/overview)-computer interface](/brain-regions/overview)-computer-interface) Technologies — Overview of [BCI](/brain-regions/overview)-computer-interface) platforms
- Kernel — High-precision research [EEG](/technologies/eeg))
- NextMind — Consumer SSVEP device
- Artificial Intelligence in [neurodegeneration](/diseases/neurodegeneration) Research — ML for biomarker discovery
- fMRI [neurodegeneration](/diseases/neurodegeneration) — High-resolution neuroimaging
See Also
- [Cell Types Overview](/cell-types)
- [Gene Overview](/genes)
- [Disease Overview](/diseases)
External Links
- [OpenBCI Official Website](/companies/openbci)
- [OpenBCI Forum](/companies/openbci)
- [OpenBCI GitHub](/companies/openbci)
- [BrainFlow Documentation](/genes/nfl)
References
Unknown, OpenBCI. Open Source EEG) Hardware and Software. Accessed 2024 (2024)
McCrimmon CM et al, A portable, wireless, programmable neural recording system for freely behaving rodents (2017)
Unknown, BrainFlow Development Team. BrainFlow: Unified API for brain-computer interface](/brain-regions/overview)-computer-interface) Research. 2024 (2024)
Dauwan M et al, EEG)-based dynamics of Alzheimer's disease](/diseases/alzheimers-disease): a systematic review (2021)
Cassani R et al, A systematic review of quantitative EEG) for Alzheimer's disease](/diseases/alzheimers-disease) (2023)
Musaeus CS et al, Electroencephalographic connectivity as a biomarker for Alzheimer's disease](/diseases/alzheimers-disease) (2022)
Mo J et al, Electroencephalographic for Parkinson's disease](/diseases/parkinsons-disease): a systematic review (2023)
Sharma A et al, EEG)-based machine learning for Parkinson's disease](/diseases/parkinsons-disease) diagnosis and monitoring (2023)
Wolpaw JR et al, brain-computer interfaces for communication and control (2002)
Kübler A et al, brain-computer communication: the challenge of chronic use (2009)
Babiloni C et al, Italian version of the European Alzheimer's disease](/diseases/alzheimers-disease) consortium (EADC) consensus on EEG) markers for Alzheimer's disease](/diseases/alzheimers-disease) and mild cognitive impairment (2019)
Liew CL et al, Neurofeedback for cognitive enhancement in Alzheimer's disease](/diseases/alzheimers-disease): a systematic review (2022)
Huster RJ et al, Methods for simultaneous EEG)-fMRI: an introductory review (2012)
Chiarelli AM et al, Merging EEG) and fNIRS: a promising tool for brain monitoring (2016)
Petersen RC et al, electroencephalography in dementia: a systematic review of current knowledge (2022)